Navigation Links
ICOS in Medical News

Amylin Sends Letter to Shareholders

...g. In addition, this year we have put up for election two new nominees: Paul N. Clark, former Chairman, Chief Executive Officer and President of icos Corporation, and Paulo F. Costa, former President and Chief Executive Officer of Novartis U.S. Corporation. Both are widely respected business leader...

AAI honors Chen Dong for breakthrough T lymphocyte research

... of IL-17. "So we thought maybe IL-17 is more important than interferon-gamma in autoimmune diseases," Dong said. IL-17 also turns out to rely on the icos receptor that was missing from the T cells of the mutant mice. Paper reveals new path to autoimmune and inflammatory diseases Dong's subsequent ...

Amylin Pharmaceuticals Announces Slate of Directors for Annual Meeting of Stockholders

...re Paul N. Clark, former Chairman, Chief Executive Officer and President of icos Corporation and Paulo F. Costa, former President and Chief Executive Office...l since 2007. Prior to joining Genstar, he served in numerous capacities at icos Corporation, including Director, Chief Executive Officer, President and Cha...

Lilly Reports Fourth-Quarter and Full-Year 2008 Results

...d in the reconciliation tables and also assume the icos acquisition was completed January 1, 2007. The pro...opment charges associated with the acquisitions of icos ($303.5 million), Hypnion ($291.1 million) and Ivy... - .06 Pro forma as if the icos acquisition was completed on January 1, 2007...

Quorum Review IRB Appoints Michael Malafronte Director of Quality and Document Administration

...edge," explains Cami Gearhart, CEO. Prior to joining Quorum Review IRB, Mr. Malafronte directed quality groups at Nastech Pharmaceuticals, icos Corporation, and Abbott Labs. "It is a pleasure to be heading up the Quality Management and Document Administration teams at Quorum Review,"...

Lilly Caps Successful Year with Strong Fourth-Quarter Results

...he reconciliation tables below and also assume the icos acquisition was completed January 1, 2006. The pro...om the joint- venture countries prior to the icos acquisition on January 29, 2007. Total world...rtization of the intangible assets acquired in the icos acquisition, offset in part by manufacturing expen...

Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy

...es later in this press release and also assume the icos acquisition was completed January 1, 2006. For 200...he charges noted in the table below and assume the icos acquisition was completed January 1, 2006. Includi... .63 - Include pro forma as if the icos acquisition was completed (.01) (....

CellCyte Genetics Corp. Appoints Tony Colasin as Director of Business Development

...s(R) pre-commercialization team created to develop icos sales force's strategy/configuration and pre-launc...activities to establish brand character. While at icos Corporation, he also secured a co-promotion agreem...ulti-million dollar co-promotion agreement for the icos sales force. He is also attributed with negotiatin...

Lilly Delivers Strong Third-Quarter Results

...he reconciliation tables below and also assume the icos acquisition was completed January 1, 2006. The pro...from the joint-venture countries prior to the icos acquisition on January 29, 2007. Total worldw... .06 - Include pro forma as if the icos acquisition was completed on January 1, 2006...

Cialis Eases Erectile Dysfunction After Spinal Cord Injury

...fects among the men who took Cialis were headache (8.5 percent) and urinary tract infection (7.7 percent). The study, funded by Cialis' maker Lilly icos LLC, was posted online Sept. 10 and is expected to be published in the November print issue of the journal Archives of Neurology . More informati...

More>>

ICOS in Medical Technology

CMC ICOS Biologics and Implicit Bioscience Ltd Announce IC14 Antibody Manufacturing Agreement and Patent License

BOTHELL, Wash. and BRISBANE, Australia, May 8 /PRNewswire/ -- Implicit Bioscience Ltd and CMC ICOS Biologics today announced the execution of a manufacturing contract to support the next stage of development and commercialization of IC14, a clinical-stage monoclonal antibody for acute lung injury ...

Lilly and Glenmark Pharmaceuticals Announce License Agreement

... - .31 Include pro forma as if the icos acquisition was completed on January 1, 2006 - ... and OSI in-licensing .58 - Include pro forma as if the icos acquisition was completed on January 1, 2006 (.01) ...

Study: Identical Doses of BiDil Components Are Not Bioequivalent to the Fixed Dose Combination-BiDil-Used in A-HeFT

...f Pfizer, Inc.; Levitra is a registered trademark of Bayer HealthCare, GlaxoSmithKline, and Schering-Plough; Cialis is a registered trademark of Lilly icos LLC. About NitroMed, Inc. NitroMed of Lexington, Massachusetts is a research-based emerging pharmaceutical company and the maker of BiDil, an oral...
ICOS in Biological Technology

Oncothyreon appoints Scott Peterson as Vice President of Research and Development

...ication in oncology. From 1999 until 2007 he held a variety of positions at icos Corporation in Bothell, Washington, most recently as a Principal Scientist in Oncology Drug Discovery. At icos he was involved in both small molecule and antibody development. Dr. Peters...

ClearTrial Industry Expert to Lead Session at DIA Annual Meeting on Improving Accrual and Contract Management in Clinical Trials

...g and contract management. Before joining ClearTrial, she led the Financial Administration division for the Clinical Business Management department at icos Corporation (an Eli Lilly company), where she worked on the blockbuster drug Cialis®. At ICOS, Lucas was responsible for establishing best practic...

Amylin Comments on RiskMetrics Report

...and embraced the need for change, with two new independent Director nominees, Paul N. Clark, former Chairman, Chief Executive Officer and President of icos Corporation, and Paulo F. Costa, former President and Chief Executive Officer of Novartis U.S. Corporation. Both bring additional commercial and oper...

Amylin Pharmaceuticals Provides Shareholders with Update Regarding Recent Developments

...s of all our shareholders. The two new independent nominees to our Board are Paul N. Clark, former Chairman, Chief Executive Officer and President of icos Corporation, and Paulo F. Costa, former President and Chief Executive Officer of Novartis U.S. Corporation. Both possess valuable commercial and oper...

Implicit Licenses Clinical Stage Antibody Program From Lilly

... is an excellent opportunity, and a good fit to our capabilities and business model." IC14 had earlier been in development for severe sepsis at icos Corporation which was acquired by Lilly in 2007. It has been used in the treatment of more than 150 patients, and has well characterized safety and ph...

ClearTrial Selected to Lead Industry Panel on Managing Clinical Trial Cash Flow and Accruals at CBI Conference

... and contract management. Before joining ClearTrial, she led the Financial Administration division for the Clinical Business Management department at icos Corporation (an Eli Lilly company), where she worked on the blockbuster drug Cialis®. At ICOS, Lucas was responsible for establishing best practi...

MedImmune Presents Data Highlighting its Progressive Inflammatory Disease Portfolio at the 72nd Annual Meeting of the American College of Rheumatology

...CAM-3001 is a phase 1 clinical stage program. -- icos - icos (Inducible costimulator) is a receptor on activate...ntral role in humoral immunity. Elevated levels of icos are present in patients with autoimmune disea...

Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman

...erved as an independent director of Anthera since 2006. Dr. Henney is a co-founder of three major publicly held U.S. biotechnology companies: Immunex‚ icos and Dendreon‚ and has been associated with the formation of several others. Most recently Dr. Henney has served as Chairman and Chief Executive Office...

Lilly Reports Solid Second-Quarter Results

...ales from the joint-venture countries prior to the icos acquisition on January 29, 2007. Total worldw...d IPR&D charges associated with the acquisition of icos of $303.5 million and the licensing arrangement wi... (.19) - Include pro forma as if the icos acquisition was completed on January 1, 2007...

Lilly Reports Solid First-Quarter Results

...rom the joint-venture countries prior to the icos acquisition on January 29, 2007. Total world... the acquisition of ICOS, the results of the Lilly icos joint venture were presented in other income. Subs...elopment charge associated with the acquisition of icos was not deductible. Reported net income and earn...
Other Tags
(Date:4/22/2014)... release is available in German . ... important intracellular signaling molecules, but their mode of action ... of cellular function and behavior, while at high concentrations ... and DNA. To analyze how redox signaling unfolds in ... microscopy technique has been developed jointly by the teams ...
(Date:4/22/2014)... help rein in massive health care spending, a new ... find ways to incentivize pharmaceutical companies and device makers ... of examining existing medical technologies and their use, a ... what drugs and medical devices get created in the ... care spending with as little loss of health as ...
(Date:4/22/2014)... all seem to know who we say is neurotic and ... unable to act but simply doesn,t want to., ... of nearly 4,000 college students in 19 countries has uncovered ... and moving forward with life. Turns out that when they ... don,t like it as much as non-neurotics. Therefore persuasive communications ...
(Date:4/22/2014)... demonstrated the first size-based form of chromatography that ... living cells. This unique physical approach to probing ... whether a cell lives or dies, remains normal ... conventional microscopy. , "We,ve developed membrane-embedded nanodot array ... probe and manipulate membrane assemblies, including signaling clusters, ...
(Date:4/22/2014)... release is available in German . ... Laboratories of the University of Vienna and the Medical University ... now shown how double stranded RNA, such as viral genetic ... During the immune response against viral infection, the protein ADAR1 ... it modifies viral RNA to inhibit reproduction of the virus. ...
Breaking Medicine News(10 mins):Health News:Neuroimaging: Live from inside the cell 2Health News:US medical innovation needs smarter incentives to cut health spending, study finds 2Health News:US medical innovation needs smarter incentives to cut health spending, study finds 3Health News:Neurotics don't just avoid action: They dislike it 2Health News:First size-based chromatography technique for the study of livi 2Health News:First size-based chromatography technique for the study of livi 3Health News:How the body fights against viruses 2Health News:How the body fights against viruses 3
(Date:4/23/2014)... A biomedical engineer at the University of Houston ... make blood transfusions safer. His work is supported by ... Health (NIH). , Blood transfusions save millions of ... absolute necessities. Without them, for instance, routine surgeries would ... however. There,s strong evidence that transfusions of red blood ...
(Date:4/23/2014)... used to read quickly. It involves visual searching ... and/ or sentences. Similarly to humans, biological systems ... genetic information. Genes that need to be read ... encoding message, the easier it will be to ... de Cincia (IGC, Portugal) and Centre for Molecular ...
(Date:4/23/2014)... one can argue that if we were to follow a ... we canthen we can solve the climate problem without doing ... climate researchers, in the current issue of Bulletin of ... significant action on climate change now makes it more likely ... Wigley explains in an exclusive Bulletin interview. ...
Breaking Biology News(10 mins):UH biomedical engineer works to make blood transfusions safer 2UH biomedical engineer works to make blood transfusions safer 3Cell division speed influences gene architecture 2Is nuclear power the only way to avoid geoengineering? 2
Other Contents